Quest Diagnostics, headquartered in Secaucus, New Jersey, employs 40,000 staff and provides diagnostic testing services to physicians, hospitals, and patients through a nationwide network. The company utilizes AI and digital solutions to enhance laboratory functions and support biopharmaceutical companies.
DGX has been in the news recently: Quest Diagnostics (DGX) is set to announce its quarterly earnings on July 22, 2025, which is significant for investors. In Q2 2025, the company exceeded analyst expectations with notable sales and earnings growth, prompting an increase in its full-year guidance.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!